Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 208366
Company: APOTEX
Company: APOTEX
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
MICAFUNGIN SODIUM | MICAFUNGIN SODIUM | EQ 50MG BASE/VIAL | INJECTABLE;INTRAVENOUS | Discontinued | None | No | No |
MICAFUNGIN SODIUM | MICAFUNGIN SODIUM | EQ 100MG BASE/VIAL | INJECTABLE;INTRAVENOUS | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
11/05/2020 | ORIG-1 | Approval | STANDARD |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/208366Orig1s000TAltr.pdf |